ロード中...
Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate.
The bisphosphonate pamidronate (3 amino-1, 1-hydroxypropylidene bisphosphonate (APD), Ciba-Geigy) is a powerful inhibitor of osteoclast function and has been shown to significantly reduce osteolysis associated with bone metastases in breast cancer. Until recently, however, only an intravenous prepar...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
1990
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1971333/ https://ncbi.nlm.nih.gov/pubmed/2297483 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|